I should add, that in addition to increased marketing and distribution costs, the company plans to invest a 'moderate' amount in product development. It would be nice to get a feel for what 'moderate' means. It doesn't sound like much, but again I'm erring on the side of caution.
What's not to like about this company?, a blockbuster product with plenty of room for growth, now generating surplus free cashflow and debt free. Very tempting in the current environment.
- Forums
- ASX - By Stock
- prelim report
I should add, that in addition to increased marketing and...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CST (ASX) to my watchlist
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online